NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
17/09/2024
Voltar para busca
Dado oficial do USPTO
BEAUFORT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
21
Atualização mais recente
17/09/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
35, 40, 42, 45
Data de depósito
13/01/2023
Data de registro
17/09/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/09/2024
Última transação
17/09/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
05/12/2022
Primeiro uso no comércio
05/12/2022
Código do desenho
3
Tipo de titular
16
Localização do titular
Virginia Beach, VA
Examinador
FRENCH, CURTIS
Unidade examinadora
M60
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of an image comprised of the shape of a light-blue, 90-degree angle open to the right and facing the shape of a dark-blue, 90-degree angle open to the left, the two angles having the shape of a green sphere centered between them, and the word "BEAUFORT" written in dark-blue letters to the right of the image.
Titulares e representantes
Titulares
BEAUFORT, LLC
Representantes
WILLCOX & SAVAGE, P.C.
Classificação técnica
Classes Nice
Classe 35Classe 40Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Regulatory submission managementassisting others in preparing Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; database management; organizing and administering a network of research sitesbusiness consultation and management in the field of clinical trialsspecificallyproviding governmental registration assistance in the nature of regulatory submission management on behalf of research sites that conduct gene therapy and vaccine research to assist them with clinical research and clinical trials; providing institutional biosafety committee servicesproviding independent review and oversight of clinical trials involving genetically engineered gene therapy and vaccine research for business purposes
Classe 40
Consulting services in the field of manufacturing compliance and validationproviding technical advice related to the manufacture of pharmaceuticals
Classe 42
Contract research organization (CRO) servicesmonitoring of clinical trials for investigational drugs of biotech and pharmaceutical companiesclinical trial project management and quality assurancemedical writing of investigational drug protocolsmedical research in the nature of biostatistical analysis; consulting services in the field of conducting clinical trialsdrug developmentmanufacturing environmental compliance and validationadvanced technology in the pharmaceutical fieldmedical research in the nature of clinical benchmarking used to improve the performance of professionals in the fields of international healththe pharmaceutical industrythe biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for othersproviding implementation services relating to the development and validation of drugsdevices and biologics; providing institutional biosafety committee servicesreview and oversight of clinical trials involving genetically engineered gene therapy and vaccine researchspecificallyevaluating research sites involved in gene therapy and vaccine research clinical trials to determine whether the organizations conform to an established accreditation standard; assessing the readiness of research sites to conduct gene therapy and vaccine researchtestinganalysisevaluation of gene therapy and vaccine research service providers to determine conformity with established accreditation standards; consultation services in the nature of quality managementquality evaluation and analysisquality assurancequality control in the field of clinicalmedicalbiological research studies; consultation services in the field of drug and medical device development; consultation services in the field of conducting clinical trials for others; consultation services in the field of scientific research complianceanalysis and evaluation of scientific research of others in the field of clinical trials involving human subjects to assure compliance with industry standards; consultation services in the field of scientific research administration and operations in the field of clinical trials involving human subjects; consultation services in the field of product research and development and scientific research and development
Classe 45
Legal researchregulatory research in the pharmaceutical industrybiotechnology industry and the medical and diagnostics industry; consultation in the field of regulatory compliance to ensure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory and compliance audits for othersreviewing standards and practices to assure compliance with laws and regulations in the fields of pharmaceuticalveterinarypharmacogenomicbiotechnical and medical products and devices; providing information relating to legal affairsproviding regulatory information relating to the development and validation of drugsdevices and biologics; regulatory compliance consulting as it applies to clinical trialsmonitoring by clinical research administrators for compliance with regulations governing clinical trials; legal document preparation servicespreparation of Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; consulting services in the field of regulatory affairs and manufacturing compliance and validationregulatory compliance consulting as it applies to prescription drug sampling; consulting services in the field of clinical benchmarking and performance improvementproviding independent review of clinical trials involving human subjects in the nature of reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; providing regulatory compliance consultation services in the nature of advice concerning due diligencestrategic developmentregulatory policy in the field of clinical trials involving human subjects; providing information relating to regulatory compliance for independent review of clinical trials involving human subjects; providing institutional biosafety committee servicesindependent review and oversight of clinical trials involving genetically engineered gene therapy and vaccine researchspecificallyreviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; assessing the readiness of research sites to conduct gene therapy and vaccine researchreviewing standards and practices to assure compliance with laws and regulations in the field of clinical trials involving human subjects; regulatory compliance consultation services in the nature of health inspection readiness and remediation in the field of clinicalmedicalbiological research studies; consultation services in the field of pharmacovigilance strategies to ensure regulatory compliance and patient safety in the field of clinical trials involving human subjects; regulatory compliance consultation services in the field of informed consent protocols for clinical trial participants; consultation services in the field of research complianceregulatory compliance consultation services in the field of clinical trials involving human subjects
Publicações
Histórico de despachos e eventos da marca no USPTO.
21 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
17/09/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
15/08/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
15/08/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/08/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/08/2024
IUAF
USE AMENDMENT FILED
17/06/2024
EISU
TEAS STATEMENT OF USE RECEIVED
17/06/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
14/06/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/06/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/06/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/06/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
16/01/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/11/2023
PUBO
PUBLISHED FOR OPPOSITION
21/11/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/11/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/10/2023
DOCK
ASSIGNED TO EXAMINER
10/10/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/02/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/02/2023
NWAP
NEW APPLICATION ENTERED
17/01/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BEAUFORT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.